I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Soulard, S
101
results:
Search for persons
X
Format
Online (101)
Mediatypes
Articles (Online) (45)
Bookchapter (Online) (4)
OpenAccess-fulltext (52)
Languages
english (85)
french (12)
Sorted by: Relevance
Sorted by: Year
?
1
HSD1 Treatment With Dual and Triple Therapy in Chronic Obst..:
Janson, C
;
Hernando Platz, J
;
Soulard, S
...
Value in Health. 25 (2022) 12 - p. S273 , 2022
Link:
https://doi.org/10.1016/..
?
2
HSD2 Reusable Soft Mist Inhalers Have an Improved Carbon Fo..:
Janson, C
;
Hernando Platz, J
;
Soulard, S
...
Value in Health. 25 (2022) 12 - p. S273 , 2022
Link:
https://doi.org/10.1016/..
?
3
Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidon..:
Rinciog, C.
;
Diamantopoulos, A.
;
Gentilini, A.
...
PharmacoEconomics - Open. 4 (2020) 3 - p. 449-458 , 2020
Link:
https://doi.org/10.1007/..
?
4
PRS30 Cost-Effectiveness of the Fixed-Dose Combination Tiot..:
Hoogendoorn, M.
;
Corro Ramos, I.
;
Soulard, S.
...
Value in Health. 23 (2020) - p. S722 , 2020
Link:
https://doi.org/10.1016/..
?
5
PRS19 BURDEN OF DISEASE OF FIBROSING INTERSTITIAL LUNG DISE..:
Wuyts, W.
;
Rømhild Davidsen, J.
;
Kilpeläinen, M.
...
Value in Health. 22 (2019) - p. S875-S876 , 2019
Link:
https://doi.org/10.1016/..
?
6
PSY105 - COST-UTILITY OF NINTEDANIB VERSUS PIRFENIDONE FOR ..:
Soulard, S.
Value in Health. 21 (2018) - p. S454 , 2018
Link:
https://doi.org/10.1016/..
?
7
Market Access of Nintedanib for Idiopathic Pulmonary Fibros..:
Picavet, E
;
Soulard, S
;
Druez, C
.
Value in Health. 20 (2017) 9 - p. A566 , 2017
Link:
https://doi.org/10.1016/..
?
8
Systematic Review of The Cost-Effectiveness of Medicines Fo..:
Soulard, S
;
Wammes, K
;
Picavet, E
..
Value in Health. 20 (2017) 9 - p. A555 , 2017
Link:
https://doi.org/10.1016/..
?
9
Potential Savings Achieved Through Switching COPD Patients ..:
Fens, T
;
Postma, MJ
;
Voorhaar, M
..
Value in Health. 20 (2017) 9 - p. A650 , 2017
Link:
https://doi.org/10.1016/..
?
10
Cost-Effectiveness of Dabigatran vs. Rivaroxaban and Vitami..:
Schoenherr, N
;
Soulard, S
;
Crespo, C
..
Value in Health. 19 (2016) 7 - p. A651 , 2016
Link:
https://doi.org/10.1016/..
?
11
Cost-utility of nintedanib vs. Pirferidone in the treatment..:
Soulard, S
;
Crespo, C
Value in Health. 19 (2016) 7 - p. A555 , 2016
Link:
https://doi.org/10.1016/..
?
12
I-PreFer Study: A Discrete Choice Experiment to Explore Pat..:
Hollmen M
;
Wijsenbeek M
;
Bromilow T
...
https://www.dovepress.com/i-prefer-study-a-discrete-choice-experiment-to-explore-patient-caregiv-peer-reviewed-fulltext-article-PPA. , 2023
Link:
https://doaj.org/article..
?
13
I-PreFer Study: A Questionnaire to Explore Patient, Caregiv..:
Hollmen M
;
Bromilow T
;
Smith AB
...
https://www.dovepress.com/i-prefer-study-a-questionnaire-to-explore-patient-caregiver-and-pulmon-peer-reviewed-fulltext-article-PPA. , 2023
Link:
https://doaj.org/article..
?
14
Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidon..:
Rinciog, C
;
Diamantopoulos, A
;
Gentilini, A
...
boreal:226674. , 2020
Link:
http://hdl.handle.net/20..
?
15
Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidon..:
Rinciog, C
;
Diamantopoulos, A
;
Gentilini, A
...
boreal:225959. , 2020
Link:
http://hdl.handle.net/20..
1-15